同步原發性子宮內膜癌和卵巢癌之病例報告與文獻回顧

Synchronous primary endometrial and ovarian cancer: a case report and literature review

同步原發性子宮內膜癌和卵巢癌（SPEOC）是一種相對罕見的病況，不一定有明顯的 臨床表現。與子宮內膜癌和卵巢癌相比，同步子宮內膜癌和卵巢癌發病高峰年齡在
41至54歲之間，較常見於年輕，未產婦，更年期前期女性。相比於單一器官的轉移性疾病，預後被認為較好。除了潛在的預後價值之外，準確診斷這些腫瘤為原發性
癌症還是轉移性疾病，將有助於確定分期並指導治療方案。我們在此報導一位57歲女性的案例，其為同步原發性子宮內膜癌和卵巢癌，並將討論這種少見腫瘤之臨床症狀、病理型態、治療以及預後。

Synchronous primary endometrial and ovarian carcinoma (SPEOC) is a relatively rare condition with not necessarily distinct clinical manifestations. Compared to endometrial and ovarian cancers, SPEOC peaks between the ages of 41 to 54, more commonly seen in younger, nulliparous, and premenopausal women. It is believed to have a better prognosis compared to metastatic diseases affecting a single organ. In addition to its potential prognostic value, accurately diagnosing these tumors as primary carcinomas or metastatic diseases helps in staging and guides treatment strategies. Here, we report a case of a 57-year-old female with SPEOC and discuss the clinical symptoms, pathological features, treatment, and prognosis of this uncommon tumor.